Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.
暂无分享,去创建一个
D. Reece | Y. Elsayed | G. Merlini | U. Hegenbart | G. Palladini | V. Sanchorawala | J. Fermand | R. Comenzo | A. Cakana | R. Vescio | Xiangyang Liu